CrushSCI.com
提供学术论文选刊润色服务
CLINICAL CANCER RESEARCH 临时占位封面 医学
返回期刊列表

Review Cycle Records

CLINICAL CANCER RESEARCH

American Association for Cancer Research SCIE 非OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
227.2平均天数
204中位天数
133最短天数
344最长天数
2,7602025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

160 天

Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics

作者Kiwan Kim; Seong-Won Song; Yeongha Jeon; Soyoung Choi; Jiyoun Choi; Sungmin Jun; Ju-Hwang Park; Song-Jae Lee; Nayoung Han; Yun-Sik Dho; Sang-Hoon Shin; Heon Yoo; Kyu-Chang Wang; Ho-Shin Gwak

作者单位1. 1R&D center, CellabMED Inc., Seoul, Republic of Korea.; 2. 2CellabMED Inc., Seoul, Republic of Korea.; 3. 3CGT center, CellabMED Inc., Seoul, Republic of Korea.; 4. Samsung Medical Center 4 Department of Pathology and Translational Genomics, , Seoul, Republic of Korea.; 5. National Cancer Center 5 Neuro-oncology clinic, , Goyang, Republic of Korea.; 6. 6Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.

PDF源文件 DOI 网页
295 天

DNMT3B Plays Antagonistic Roles with SMARCB1 and Is a Targetable Vulnerability in Rhabdoid Tumors

作者Céline Chauvin; Ryszard Wimmer; Ludovica Brunetti; Joanna Cyrta; Ana Boranijasevic; Mamy Andrianteranagna; Julien Masliah-Planchon; Kévin Beccaria; Sandrina Turczynski; Grégory Thomson; Maëva Veyssière; Rachida Bouarich-Bourimi; Zhi-Yan Han; Owen Hoare; Aurore Coulomb; Mylène Bohec; Sylvain Baulande; Gaëlle Pierron; Olivier Delattre; Arnault Tauziède-Espariat; Nicolas Servant; Alexandre Baffet; Franck Bourdeaut

作者单位1. 1INSERM U1330, Childhood Oncology Research Unit, SIREDO Oncology Center, Institut Curie Research Center, Paris, France.; 2. Institut Curie 2 , CNRS UMR144, PSL Research University, Sorbonne University, Paris, France.; 3. Institut Curie 3 Department of Pathology, , PSL Research University, Paris, France.; 4. Institut Curie 4 INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Unit, , Mines Paris Tech, PSL Research University, Institut Curie Research Center, Paris, France.; 5. 5Somatic Genetic Unit, Department of Pathology, Diagnostic and Theranostic Medecine, Institut Curie Hospital, Paris, France.; 6. 6Department of Pediatric Neurosurgery, Necker Hospital, APHP, Université Paris Cité, Paris, France.; 7. Sorbonne Université 7 Department of Pathology, Hôpital Armand Trousseau, Assistance-Publique Hôpitaux de Paris, , Paris, France.; 8. 8Single Cell Initiative, ICGex Next-Generation, PSL Research University, Institut Curie Research Center, Paris, France.; 9. 9Department of Neuropathology, GHU Paris Psychiatry and Neurosciences, Sainte-Anne Hospital, Paris, France.; 10. 10Institut national de la santé et de la recherche médicale (Inserm), Paris, France.; 11. 11Paris Cité University, Paris, France.

PDF源文件 DOI 网页
344 天

Clinical, Genomic, and Spatial Transcriptomic Features of Pancreatic Adenosquamous Carcinoma Support Subtype-Specific Therapeutic Strategies

作者S. Daniel Haldar; Meredith Wetzel; Jiayun Lu; Jae W. Lee; Hassan Sinan; Christopher D. Jakubowski; Fen Saj; Dean Pavlick; Ryon P. Graf; Julia Quintanilha; Gerald Li; Jerry Mitchell; Jeffrey S. Ross; Anirban Maitra; Milind Javle; Shubham Pant; Hao Wang; Richard Burkhart; Daniel A. Laheru; Elizabeth M. Jaffee; Elana J. Fertig; Elizabeth D. Thompson; Dimitrios N. Sidiropoulos; Luciane T. Kagohara; Nilofer S. Azad

作者单位1. The University of Texas MD Anderson Cancer Center 1 Department of Gastrointestinal Medical Oncology, , Houston, Texas.; 2. 2Johns Hopkins Convergence Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.; 3. Sidney Kimmel Comprehensive Cancer Center 3 Department of Oncology, , , Baltimore, Maryland.; 4. Johns Hopkins University 3 Department of Oncology, , , Baltimore, Maryland.; 5. Sidney Kimmel Comprehensive Cancer Center 4 Division of Quantitative Sciences, Department of Oncology, , , Baltimore, Maryland.; 6. Johns Hopkins University 4 Division of Quantitative Sciences, Department of Oncology, , , Baltimore, Maryland.; 7. 5Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; 8. Icahn School of Medicine at Mount Sinai 6 Elmhurst Hospital Center, , Queens, New York.; 9. 7Department of Oncology, Albert Einstein College of Medicine, Bronx, New York.; 10. Foundation Medicine 8 , Boston, Massachusetts.; 11. SUNY Upstate Medical University 9 , Syracuse, New York.; 12. 10Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, New York.; 13. 11Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland.; 14. 12Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.

PDF源文件 DOI 网页
133 天

FDA Approval Summary: Erdafitinib for FGFR3 -Altered Locally Advanced or Metastatic Urothelial Carcinoma

作者William F. Maguire; Elaine Chang; Flora Mulkey; Vicky Hsu; Huali Wu; Tien M. Truong; Dana Kappel; Jeffrey Kraft; Jingyu Yu; Xin Gao; William F. Pierce; Nam Atiqur Rahman; Mallorie H. Fiero; Laleh Amiri-Kordestani; R. Angelo de Claro; Daniel L. Suzman

作者单位1. U.S. Food and Drug Administration 1 Center for Drug Evaluation and Research, , Silver Spring, Maryland.; 2. 2Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.

PDF源文件 DOI 网页
204 天

Targetable S100–RAGE Signaling Mediates Intrinsic Trastuzumab Deruxtecan Resistance in Metastatic Breast Cancer

作者Wenjuan Dong; Shiruo Wang; Bill Chan; Matthew Vasquez; Johnny Z.M. Cui; James Sampson; Caitlin Sannes; Wei Yang; Akshjot Puri; Jenny Chang; Hong Zhao; Xiaoxian Li; Stephen T.C. Wong

作者单位1. 1Systems Medicine and Bioengineering Department, Houston Methodist Neal Cancer Center, Houston, Texas.; 2. 2Advanced Cellular and Tissue Microscopy Shared Resource, Houston Methodist Research Institute and Houston Methodist Neal Cancer Center, Houston, Texas.; 3. Texas A&M University 3 School of Engineering Medicine, , Houston, Texas.; 4. 4Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; 5. 5Houston Methodist Neal Cancer Center, Houston, Texas.; 6. 6Department of Medicine, Houston Methodist Hospital and Weill Cornell Medicine, New York, New York.; 7. East Carolina University 7 Department of Pathology and Laboratory Medicine, Brody School of Medicine, , Greenville, North Carolina.; 8. 8Department of Radiology, Houston Methodist Hospital and Weill Cornell Medicine, New York, New York.

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。